Pekin Life Insurance Company (PKIN)
OTCMKTS · Delayed Price · Currency is USD
11.75
0.00 (0.00%)
Nov 9, 2026, 4:00 PM EST
PKIN Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Investments in Debt Securities | - | 1,133 | 1,431 | 1,418 | 1,418 | 1,405 |
Investments in Equity & Preferred Securities | - | 41.11 | 44.98 | 35.9 | 29.75 | 37.15 |
Policy Loans | - | 14.29 | 14.46 | 14.2 | 13.71 | 13.65 |
Total Investments | - | 1,292 | 1,607 | 1,583 | 1,573 | 1,560 |
Cash & Equivalents | - | 11.25 | 12.58 | 11.82 | 4.19 | 10.28 |
Reinsurance Recoverable | - | 0.03 | 0.77 | 0.31 | 0.28 | 1.55 |
Other Receivables | - | 45.42 | 46.91 | 44.75 | 42.29 | 39.84 |
Long-Term Deferred Tax Assets | - | 7.76 | 7.39 | 7.47 | 7.85 | 7.48 |
Other Long-Term Assets | - | 12.05 | 38.44 | 39.63 | 25.81 | 7.15 |
Total Assets | - | 1,368 | 1,713 | 1,687 | 1,653 | 1,626 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Accrued Expenses | - | 7.39 | 7.42 | 5.55 | 5.42 | 5.8 |
Insurance & Annuity Liabilities | - | 1,150 | 1,468 | 1,447 | 1,427 | 1,404 |
Unpaid Claims | - | 17.62 | 20.13 | 22.02 | 23.48 | 22.71 |
Unearned Premiums | - | 2.36 | 2.46 | 2.18 | 2.2 | 2.11 |
Short-Term Debt | - | 12.44 | 38.44 | 39.63 | 25.81 | 7.15 |
Other Current Liabilities | - | 5.54 | 7.4 | 6.54 | 6.26 | 6.69 |
Other Long-Term Liabilities | - | 31.97 | 32.76 | 38.94 | 40.58 | 46.67 |
Total Liabilities | - | 1,235 | 1,584 | 1,571 | 1,538 | 1,504 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Common Stock | - | 22 | 22 | 22 | 22 | 22 |
Additional Paid-In Capital | - | 0.9 | 0.9 | 0.9 | 0.9 | 0.9 |
Retained Earnings | - | 114.53 | 110.27 | 97.26 | 96.57 | 103.41 |
Treasury Stock | - | -4.27 | -4.27 | -4.27 | -4.27 | -4.27 |
Comprehensive Income & Other | - | 0 | - | - | - | - |
Shareholders' Equity | 133.16 | 133.16 | 128.9 | 115.89 | 115.2 | 122.04 |
Total Liabilities & Equity | - | 1,368 | 1,713 | 1,687 | 1,653 | 1,626 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Filing Date Shares Outstanding | 17.07 | 17.07 | 17.07 | 17.07 | 17.07 | 17.07 |
Total Common Shares Outstanding | 17.07 | 17.07 | 17.07 | 17.07 | 17.07 | 17.07 |
Total Debt | 12.44 | 12.44 | 38.44 | 39.63 | 25.81 | 7.15 |
Net Cash (Debt) | -1.2 | -1.2 | -25.86 | -27.81 | -21.62 | 3.13 |
Net Cash Growth | - | - | - | - | - | - |
Net Cash Per Share | -0.07 | -0.07 | -1.51 | -1.63 | -1.27 | 0.18 |
Book Value Per Share | 7.80 | 7.80 | 7.55 | 6.79 | 6.75 | 7.15 |
Tangible Book Value | 133.16 | 133.16 | 128.9 | 115.89 | 115.2 | 122.04 |
Tangible Book Value Per Share | 7.80 | 7.80 | 7.55 | 6.79 | 6.75 | 7.15 |